ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,116,284 | +99302.0% | 41,546 | +13.7% | 0.25% | +0.8% |
Q2 2023 | $1,123 | -5.1% | 36,524 | +11.2% | 0.24% | -2.0% |
Q1 2023 | $1,183 | +21.1% | 32,858 | +32.9% | 0.25% | +13.1% |
Q4 2022 | $977 | -99.9% | 24,721 | +16.1% | 0.22% | +11.1% |
Q3 2022 | $856,000 | -1.8% | 21,290 | +2.7% | 0.20% | +1.5% |
Q2 2022 | $872,000 | +20.4% | 20,723 | +11.5% | 0.20% | +41.0% |
Q1 2022 | $724,000 | +77.5% | 18,592 | +81.5% | 0.14% | +78.2% |
Q4 2021 | $408,000 | -35.4% | 10,242 | -41.4% | 0.08% | -34.5% |
Q3 2021 | $632,000 | -4.2% | 17,480 | +5.6% | 0.12% | -16.2% |
Q2 2021 | $660,000 | – | 16,560 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |